Recent News

• 09.03.2025 - Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients
• 08.11.2025 - Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2025

Recent Filings

• 09.03.2025 - EX-99.1 EX-99.1
• 09.03.2025 - 8-K Current report
• 08.28.2025 - 8-K Current report
• 08.11.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.11.2025 - 8-K Current report
• 08.11.2025 - EX-99.1 EX-99.1
• 07.30.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.29.2025 - 8-K Current report
• 07.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.25.2025 - 4 Statement of changes in beneficial ownership of securities